Trial
NCT05457959
Peptide-Pulsed Dendritic Cell Vaccination in Combination With Nivolumab and Ipilimumab for the Treatment of Recurrent and/or Progressive Diffuse Hemispheric Glioma, H3 G34-mutant
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Jonsson Comprehensive Cancer Center
Collaborators
—
Condition
Diffuse Hemispheric Glioma, H3 G34-Mutant
Intervention
Dendritic Cell Tumor Peptide Vaccine
Why stopped
Never opened
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-02-24